LINCOCIN FORTE LACTATING INTRAMAMMARY ANTIBIOTIC SOLUTION

国: オーストラリア

言語: 英語

ソース: APVMA (Australian Pesticides and Veterinary Medicines Authority)

即購入

製品の特徴 製品の特徴 (SPC)
19-06-2017

有効成分:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE; NEOMYCIN AS THE SULFATE

から入手可能:

ZOETIS AUSTRALIA PTY LTD

INN(国際名):

lincomycin as HCl (monohy.)(20mg/mL)+neomycin as sulfate(20mg/mL)

医薬品形態:

MISC. INTRA MAMMARY

構図:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 200.0 mg/10ml; NEOMYCIN AS THE SULFATE ANTIBIOTIC Active 200.0 mg/10ml

パッケージ内のユニット:

20x10mLPls

クラス:

VM - Veterinary Medicine

製:

ZOETIS AUSTRALIA

治療群:

CATTLE LACTATING | BOVINE

治療領域:

ANTIBIOTIC & RELATED

適応症:

ANTIBIOTIC - ANTI-INFECTIVE | ABRASIONS | ABSCESSES | AIRSACCULITIS | ANTISEPTIC | AVIAN MYCOPLASMAS | BLACKHEAD | BODY ODOURS | BOWED TENDONS | BROAD SPECTRUM | BURNS | COCCIDIOSIS | COLIFORM COMPLEX | CONJUNCTIVITIS | COWPOX | CRACKS | CRUSTS | DANDRUFF | DERMATOLOGICAL DISORDERS | DERMATOSIS | DRY SKIN | DYSENTERY | ECZEMA | ENDOMETRITIS | ENTERIC DISEASES | ENZOOTIC PNEUMONIA | FEED EFFICIENCY | FUNGAL INFECTIONS | GIRTH GALLS | INFECTIONS | INFLAMMED PADS | ITCHING | KERATOLYTIC | LACERATIONS | MASTITIS | MYCOPLASMAS | ODOURS | OPEN WOUNDS | OTITIS | PRURITIS | QUEENSLAND ITCH | RESPIRATORY DISEASE | SADDLE RASH | SALMONELLOSIS | SCABS | SCALY SKIN | SHEATH ROT | SKIN IRRITATIONS | SORES | SWINE DYSENTERY | TEAT CRACKING | TEAT INFECTIONS | TOPICAL INFECTIONS | UDDER SORES | WEIGHT GAIN | WIRE CUTS | WOUNDS

製品概要:

Poison schedule: 4; Withholding period: WHP: Meat: Do not use less than 30 day s before slaughter for human consumptio n. Milk: Milk collected from cows withi n 96 hours (8 milkings) following trea tment must not be used for human consum ption or processing. This milk should not be fed to bobby calves.; Host/pest details: CATTLE LACTATING: [ANTIBIOTIC - ANTI-INFECTIVE]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE LACTATING: [ANTIBIOTIC - ANTI-INFECTIVE]; For the treatment of bovine mastitis, in lactating cattle only, by intramammary infusion.

認証ステータス:

Stopped

承認日:

2022-07-01

製品の特徴

                                PRODUCT NAME: LINCO-SPECTIN® ANTIBIOTIC INJECTABLE SOLUTION
PAGE: 1 OF 5
THIS REVISION ISSUED: FEBRUARY, 2005
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: (02)9850 3333
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: (02) 9850 3333
Fax: (02) 9850 3519
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Active ingredients are antibiotics.
TRADE NAME:
LINCO-SPECTIN® ANTIBIOTIC INJECTABLE SOLUTION
PFIZER MSDS CODE:
MSDS092
PRODUCT USE:
Antibiotic vaccine for use as described on the product label.
CREATION DATE:
JANUARY, 2005
REVISION DATE:
JANUARY, 2005
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of NOHSC
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Colourless to slightly yellow solution. May have a slight haze.
ODOUR:
No data
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
Repeated overexposure to lincomycin may cause abdominal cramps,
diarrhoea and colitis. This may begin several
weeks after exposure has ceased. Some hematopoietic effects have been
reported with the use of lincomycin.
Hypersensitivity reactions have been reported in people known to be
sensitive to penicillin. Rare instances of
erythema multiforme, some resembling Stevens-Johnsone Syndrome, have
been associated with lincomycin
hydrochloride.
INHALATION
SHOR
                                
                                完全なドキュメントを読む